1) EBV-DNA
EBV-DNA
1.
Quantification and clinical application of plasma cell-free EBV-DNA,serum CYFRA21-1 and TSGF in patients with nasopharyngeal carcinoma;
鼻咽癌患者血浆EBV-DNA、血清CYFRA21-1、TSGF的检测及临床应用
2.
In the way of EDTA-Na2 to combat coagulation and depart the lymphocyte in the blood with the lymphocyte fluid and enlarge and gain the examination by the EBV-DNA model in the lymphocyte from DNA collects fluid.
方法采用实时荧光定量基因扩增技术,抽取鼻咽癌患者静脉血2mL,用EDTA-Na2抗凝,用淋巴细胞分离液分离血中淋巴细胞,再用DNA提取液提取淋巴细胞中的EBV-DNA为模板进行扩增检测。
3.
Recently,it was reported that EBV-DNA quantitive assay in plasma had some clinical significance to NPC early diagnosis.
新近研究发现鼻咽癌患者血浆EBV-DNA定量检测在鼻咽癌早期诊断中有一定的价值,但EBV-VCA/IgA和EBV-DNA在鼻咽癌治疗过程中动态变化研究尚缺。
2) EBV DNA
EBVDNA
1.
Objective To study the clinical significance of plasma EBV DNA concentration in diagnosis,differential diagnosis,clinical staging in nasopharyngeal carcinoma.
目的通过检测血浆中游离EBVDNA水平,探讨其在鼻咽癌诊断、鉴别诊断、临床分期中的临床意义。
3) EBV–DNA
EBV–DNA
1.
Objective To elucidate the diagnostic value of quantitative analysis of plasma EBV–DNA in patients with nasopharyngeal carcinoma.
方法:采用荧光定量聚合酶链反应(fluorescence quantitative polymerase chain reaction,FQ-PCR)技术,测定35例病理确诊的鼻咽癌患者血浆EBV–DNA含量,并与50例健康对照者相比较。
补充资料：DNA分子花窗(沿B―DNA轴线方向看)
[图]
说明：补充资料仅用于学习参考，请勿用于其它任何用途。